{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:29:07Z","timestamp":1790706547201,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Previous studies demonstrated that CD4<jats:sup>+<\/jats:sup> T cells can uptake tumor antigen-pulsed dendritic cell-derived exosomes (DEXO), which harbor tumor antigen peptide\/pMHC I complex and costimulatory molecules and show potent effects on inducing antitumor immunity. However, in preliminary study, CD4<jats:sup>+<\/jats:sup> T cells targeted by leukemia cell-derived exosomes (LEXs) did not show the expected effects in inducing effective anti-leukemia immunity, indicating that LEX is poorly immunogenetic largely due to an inadequate costimulatory capacity. Therefore, LEX-based anti-leukemia vaccines need to be optimized. In this study, we constructed a novel LEX-based vaccine by combining CD4<jats:sup>+<\/jats:sup> T cells with costimulatory molecules gene-modified LEXs, which harbor upregulated CD80 and CD86, and the anti-leukemia immunity of CD80 and CD86 gene-modified LEX-targeted CD4<jats:sup>+<\/jats:sup> T cells was investigated. We used lentiviral vectors encoding CD80 and CD86 to successfully transduced the L1210 leukemia cells, and the expression of CD80 and CD86 was remarkably upregulated in leukemia cells. The LEXs highly expressing CD80 and CD86 were obtained from the supernatants of gene-transduced leukemia cells. Our data have shown that LEX-CD8086 could promote CD4<jats:sup>+<\/jats:sup> T cell proliferation and Th1 cytokine secretion more efficiently than control LEXs. Moreover, CD4<jats:sup>+<\/jats:sup> T<jats:sub>LEX-CD8086<\/jats:sub> expressed the acquired exosomal costimulatory molecules. With acquired costimulatory molecules, CD4<jats:sup>+<\/jats:sup> T<jats:sub>LEX-CD8086<\/jats:sub> can act as APCs and are capable of directly stimulating the leukemia cell antigen-specific CD8<jats:sup>+<\/jats:sup> CTL response. This response was higher in potency compared to that noted by the other formulations. Furthermore, the animal study revealed that the CD4<jats:sup>+<\/jats:sup> T<jats:sub>LEX-CD8086<\/jats:sub> significantly inhibited tumor growth and prolonged survival of tumor-bearing mice than other formulations did in both protective and therapeutic models. In conclusion, this study revealed that CD4<jats:sup>+<\/jats:sup> T<jats:sub>LEX-CD8086<\/jats:sub> could effectively induce more potential anti-leukemia immunity than LEX-CD8086 alone, suggesting that the utilization of a costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4<jats:sup>+<\/jats:sup> T cell vaccine may have promising potential for leukemia immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1043484","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T07:07:25Z","timestamp":1668582445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4+ T cell vaccine efficiently enhances anti-leukemia immunity"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiaqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siguo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11899-020-00591-4","article-title":"Novel therapies in the treatment of adult acute lymphoblastic leukemia","volume":"15","author":"Gavralidis","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI130520","article-title":"SHP2 inhibition reduces leukemogenesis in models of combined genetic and epigenetic mutations","volume":"129","author":"Pandey","year":"2019","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3016","article-title":"Novel approaches to acute myeloid leukemia immunotherapy","volume":"24","author":"Beyar-Katz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1509318","article-title":"Elderly acute lymphoblastic leukemia: a Mayo clinic study of 124 patients","volume":"60","author":"Miller","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01765-8","article-title":"Engineered cellular immunotherapies in cancer and beyond","volume":"28","author":"Finck","year":"2022","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.176362","article-title":"MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric b-lymphoblastic leukemia","volume":"103","author":"Evensen","year":"2018","journal-title":"Haematologica"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-639138","article-title":"MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia","volume":"126","author":"Jones","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2558","article-title":"Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia","volume":"45","author":"Meyer","year":"2013","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142030","article-title":"Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes","volume":"131","author":"Roselli","year":"2021","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0184-6","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081175","article-title":"Approach to the adult acute lymphoblastic leukemia patient","volume":"8","author":"Sas","year":"2019","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1182\/asheducation-2018.1.25","article-title":"No free rides: management of toxicities of novel immunotherapies in ALL, including financial","volume":"2018","author":"Jain","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-785873","article-title":"Vaccine therapy in hematologic malignancies","volume":"131","author":"Avigan","year":"2018","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7150\/jca.62123","article-title":"Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1089\/cbr.2007.368-R","article-title":"Review: cancer immunotherapy by exosome-based vaccines","volume":"22","author":"Hao","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000484677","article-title":"Enhancement of anti-leukemia immunity by leukemia-derived exosomes Via downregulation of TGF-beta1 expression","volume":"44","author":"Huang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1319044","article-title":"Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer","volume":"6","author":"Xiao","year":"2017","journal-title":"Oncoimmunology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1779991","DOI":"10.1080\/2162402X.2020.1779991","article-title":"Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy","volume":"9","author":"Naseri","year":"2020","journal-title":"Oncoimmunology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2126","article-title":"Exosomes as potent cell-free peptide-based vaccine. i. dendritic cell-derived exosomes transfer functional MHC class i\/peptide complexes to dendritic cells","volume":"172","author":"Andre","year":"2004","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni854","article-title":"Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes","volume":"3","author":"Thery","year":"2002","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2567.2006.02483.x","article-title":"Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity","volume":"120","author":"Hao","year":"2006","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2567.2006.02483.x","article-title":"Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity","volume":"120","author":"Hao","year":"2007","journal-title":"Immunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091463","article-title":"Dendritic cells pulsed with leukemia cell-derived exosomes more efficiently induce antileukemic immunities","volume":"9","author":"Yao","year":"2014","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.05.058","article-title":"Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities","volume":"436","author":"Yao","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.7.3967","article-title":"Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responses","volume":"174","author":"Kennedy","year":"2005","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0407249","article-title":"Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory","volume":"82","author":"Hao","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13402-020-00535-3","article-title":"Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules","volume":"43","author":"Hu","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-016-0453-3","article-title":"Functions of cancer-derived extracellular vesicles in immunosuppression","volume":"65","author":"Czernek","year":"2017","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20812","article-title":"Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8126","article-title":"Dendritic cells loaded with HeLa-derived exosomes simulate an antitumor immune response","volume":"15","author":"Ren","year":"2018","journal-title":"Oncol Lett"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2028-5","article-title":"TGF-beta1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model","volume":"66","author":"Huang","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.12.7497","article-title":"A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells","volume":"174","author":"Xiang","year":"2005","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3041019","article-title":"The dichotomy of tumor exosomes (TEX) in cancer immunity: Is it all in the context","volume":"3","author":"Kunigelis","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29100","article-title":"Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice","volume":"136","author":"Gu","year":"2015","journal-title":"Int J Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)00056-4","article-title":"From synapses to immunological memory: the role of sustained T cell stimulation","volume":"12","author":"Lanzavecchia","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1214","article-title":"Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules","volume":"106","author":"Palena","year":"2005","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.1999.00835.x","article-title":"The role of B7 costimulation in T-cell immunity","volume":"77","author":"Harris","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000484","article-title":"Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma","volume":"36","author":"Zhang","year":"2010","journal-title":"Int J Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(98)00059-9","article-title":"Functional expression of CD80 and CD86 allows immunogenicity of malignant b cells from non-hodgkin's lymphomas","volume":"27","author":"Chaperot","year":"1999","journal-title":"Exp Hematol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2012.07.006","article-title":"Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro","volume":"148","author":"Marton","year":"2012","journal-title":"Immunol Lett"},{"key":"B50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.5.2731","article-title":"Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses","volume":"179","author":"Hao","year":"2007","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.v26.i1.10","article-title":"MHC transfer from APC to T cells following antigen recognition","volume":"26","author":"Wetzel","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5465","article-title":"Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response","volume":"178","author":"Adamopoulou","year":"2007","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3236","article-title":"Physiological relevance of antigen presentasome (APS), an acquired MHC\/costimulatory complex, in the sustained activation of CD4+ T cells in the absence of APCs","volume":"105","author":"Zhou","year":"2005","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1043484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T07:07:26Z","timestamp":1668582446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1043484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2022.1043484"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1043484","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"article-number":"1043484"}}